In today’s briefing:
- China ETFs: Inflows Continue to Support the Market
- Quiddity A/H Premium Weekly (Sep 1): China Life, Wide Premia Industrials, Banks Starting To Move
- Kunlun Energy (135 HK): The Story Is Still Going On
- [KE (BEKE US, BUY, TP US$24) TP Change]: Silver Lining Appear in Industry Cycle, Maintain BUY
- Why Is SHEIN Getting Into Bed with Forever 21? | Plus, More Legal and Political Challenges in US
- Aier Eye Hospital Group (300015.CH) 23H1 – Time to Face the Gap Between Ideal and Reality
- Morning Views Asia: O-Net Technologies (Group)
![](http://www.smartkarma.com/assets/plugins/a3-lazy-load/assets/images/lazy_placeholder.gif)
China ETFs: Inflows Continue to Support the Market
- Money continues to flow into mainland China ETFs taking the total inflows since 18 July to over US$25bn. This has likely helped stabilise the market and prevent a bigger fall.
- The inflows continue to be largest on ETFs tracking headline indices – CSI 300, STAR50, CSI1000, CSI 500, SSE50, ChiNext. Plus there are inflows on some sectoral and thematic ETFs.
- The skew between stocks gaining 20%+ over the period vs those dropping -20% or more has improved significantly over the last week.
Quiddity A/H Premium Weekly (Sep 1): China Life, Wide Premia Industrials, Banks Starting To Move
- The Brand-Spanking New (three weeks old) A-H Monitor has tables, charts, measures galore.
- Last week was slightly disappointing but the Recommendations Outperformed the universe.
- New stimulus measures are partly supply side, and a little bit demand side, but they’re not big enough yet to move the needle. Mainland ETF buying smells like National Team.
Kunlun Energy (135 HK): The Story Is Still Going On
- We think Kunlun Energy (135 HK) will see its operating momentum accelerate in 2H23, leading by better natural gas sales growth and sustained positive dollar margin performance.
- It has strengthened its financial position in 1H23, with net cash amounting to 36% of market cap. This has demonstrated its cash-generating capability and controlled capex.
- Its 7.0x and 6.6x PERs for FY23 and FY24 are inexpensive. Its annualised ROE of 10.6% is also attractive. There is room for the other businesses to recover in 2H23.
[KE (BEKE US, BUY, TP US$24) TP Change]: Silver Lining Appear in Industry Cycle, Maintain BUY
- KE Holdings (Beike) reported 2Q23 GTV 5.6% lower than our estimate, revenue (2.6%)/0.4% vs. our estimate/consensus, and non-GAAP NI 21.8%/42.9% higher than our estimate/consensus.
- We think 3Q23 is the trough and expect a rebound in 4Q23 as more substantial supportive policies laying out in China.
- We maintain the stock as BUY rating and raised TP by US$2 to US$24/ADS
Why Is SHEIN Getting Into Bed with Forever 21? | Plus, More Legal and Political Challenges in US
- In this insight we analyze the drivers of a new relationship between SHEIN and Forever 21
- We think SHEIN agreed to the deal in part to become more “mainstream” in the US
- We also believe SHEIN takes seriously the legal and political risks it faces ahead of US IPO
Aier Eye Hospital Group (300015.CH) 23H1 – Time to Face the Gap Between Ideal and Reality
- Aier’s revenue would be up 20%+ YoY in 2023, but one risk is the slowing growth rate of refractive/other consumption upgrading projects in the context of sluggish consumption in 23H2.
- The positive impact of aging on performance would not be able to hedge against the negative impact of declining birth rate, ultimately leading to a decline in overall performance growth.
- When Aier’s external expansion model fails and endogenous growth is lower-than-expectation, we suggest that Aier increase dividends/stock buybacks instead of ineffective expansion. This would make Aier more attractive to investors.
Morning Views Asia: O-Net Technologies (Group)
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.